NeutraKine® IL-17A Monoclonal antibody

NeutraKine® IL-17A Monoclonal Antibody for Neutralization, ELISA

Host / Isotype

Mouse / IgG1

Reactivity

Human and More (1)

Applications

Neutralization, ELISA and More (1)

Conjugate

Unconjugated

CloneNo.

1F3E3

Cat No : 69021-1-Ig

Print datasheet

Synonyms

CTLA 8, CTLA8, IL 17, IL 17A, IL17, IL-17, IL17A, IL-17A, interleukin 17A, NeutraKine® IL-17A



NeutralizationHT-1080 cell

产品信息

69021-1-Ig targets NeutraKine® IL-17A in ELISA, Neutralization, Cell treatment applications and shows reactivity with Human samples.

Tested Applications Neutralization, ELISA Application Description
Cited ApplicationsNeutralization, Cell treatment
Tested Reactivity Human
Cited Reactivityhuman
Immunogen human Humankine IL-17A protein HZ-1113 种属同源性预测
Host / Isotype Mouse / IgG1
Class Monoclonal
Type Antibody
Full Name interleukin 17A
Synonyms CTLA 8, CTLA8, IL 17, IL 17A, IL17, IL-17, IL17A, IL-17A, interleukin 17A, NeutraKine® IL-17A
Gene Symbol IL17A
Gene ID (NCBI) 3605
ENSEMBL Gene IDENSG00000112115
RRIDAB_2918841
Conjugate Unconjugated
Form Lyophilized Powder
Purification MethodProtein A purification
Storage Buffer Sterile PBS.
Endotoxin<0.1 EU/μg
ReconstitutionThis product was lyophilized from a 0.2 μm filtered solution in PBS. Reconstitute at 1.0 mg/mL in sterile H2O before use.
Stability and StorageLyophilized antibodies are stable for 1 year from the date of receipt if stored between (-20°C) and (-80°C). Upon reconstitution we recommend that the solution can be stored at (4°C) for short term or at (-20°C) to (-80°C) for long term. Repeated freeze thaw cycles should be avoided with reconstituted products.

背景介绍

IL17A, also named as IL-17, is a proinflammatory cytokine. IL-17, synthesized only by memory T cells and natural killer cells, has pleiotropic effects, mainly in the recruitment and activation of neutrophils. This cytokine regulates the activities of NF-kappaB and mitogen-activated protein kinases. This cytokine can stimulate the expression of IL6 and cyclooxygenase-2 (PTGS2/COX-2), as well as enhance the production of nitric oxide (NO). High levels of this cytokine are associated with several chronic inflammatory diseases including rheumatoid arthritis, psoriasis and multiple sclerosis. The IL-17 receptor is a type I transmembrane protein, that is widely expressed on epithelial cells, fibroblasts, B and T cells, and monocytic cells. In psoriatic skin lesions, both Th17 cells and their downstream effector molecules, e.g. IL-17 and IL-22, are highly increased.

This antibody can be used to neutralize the bioactivity of IL-17A.

发表文章

SpeciesApplicationTitle
Neutralization

Int J Chron Obstruct Pulmon Dis

IL-17A Promotes Epithelial ADAM9 Expression in Cigarette Smoke-Related COPD

Authors - Danyang Li
humanCell treatment

JCI Insight

Targeting mTOR with a sirolimus-eluting airway stent reduces pro-fibrotic TH17-cells and inhibits laryngotracheal stenosis

Authors - Kevin M Motz
Neutralization

Cell Mol Gastroenterol Hepatol

Fatty Acid Oxidation Promotes Apoptotic Resistance and Proinflammatory Phenotype of CD4+ Tissue-resident Memory T cells in Crohn's Disease

Authors - Guanzhan Liang